Researchers in New Zealand looked at the use of the meningitis vaccine MeNZB on people aged 15-30 and found gonorrhoea cases had fallen by 31% among the group.The sexually transmitted infection was previously proven to be resistant to medicine.The study, published in the Lancet, said exposure to MeNZB was "the first time a vaccine has shown any protection...